Home - Products - Angiogenesis - EGFR - Sodium Nitroprusside Dihydrate

Sodium Nitroprusside Dihydrate

CAS No. 13755-38-9

Sodium Nitroprusside Dihydrate ( Sodium nitroprusside dihydrate; Sodium Nitroferricyanide(III) Dihydrate )

Catalog No. M17986 CAS No. 13755-38-9

Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 41 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sodium Nitroprusside Dihydrate
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
  • Description
    Sodium Nitroprusside Dihydrate is a potent vasodilator working through releasing NO spontaneously in blood.
  • Synonyms
    Sodium nitroprusside dihydrate; Sodium Nitroferricyanide(III) Dihydrate
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    guanylate cyclase
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    13755-38-9
  • Formula Weight
    297.95
  • Molecular Formula
    C5H4FeN6Na2O3
  • Purity
    98%
  • Solubility
    DMSO : ≥ 46 mg/mL; 154.39 mM
  • SMILES
    [C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.[N-]=O.O.O.[Na+].[Na+].[Fe+4]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • CO-1686 hydrobromide

    A potent, highly selective, irreversible inhibitor of mutant EGFR with Ki of 21.5 nM for EGFR L858R/T790M.

  • Sapitinib

    Sapitinib (AZD-8931, AZD8931) is a equipotent, reversible inhibitor of EGFR, ErbB2 and ErbB3 with IC50 of 4. 3 and 4 nM (phosphorylation inhibition), respectively.

  • Pyrotinib

    Pyrotinib (SHR-1258)is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively.